Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when BBLG files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsBone Biologics postpones annual meeting to September 28 to add stockholder proposal
Filed July 16, 2026 · Period ending July 15, 2026 · ~1 min read
Key Changes
-
medium
Annual meeting moved from August 11 to September 28, 2026, with a new record date of August 6, to allow stockholders time to consider an additional proposal that will be included in the proxy statement.
Item 8.01 verify on EDGAR → -
medium
Stockholders have until July 26, 2026 (ten days from this filing) to submit director nominations or other proposals for the annual meeting, a compressed window due to the postponement.
Item 8.01 verify on EDGAR →
Summary
Bone Biologics postponed its 2026 annual stockholder meeting by seven weeks, from August 11 to September 28, 2026. The company's board determined additional time was necessary for stockholders to review proxy materials that will include an additional proposal not previously disclosed. The record date has been reset to August 6, 2026.
The nature of the additional proposal is not disclosed in this filing. Stockholders now have a compressed ten-day window (until July 26, 2026) to submit their own director nominations or proposals for consideration at the meeting. The postponement is procedural, though the undisclosed additional proposal warrants attention when the proxy statement is filed.
Section-by-Section Diff
Event · Item 8.01 — Other Events
Item 8.01 — Other Events filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
On July 15, 2026, the Board of Directors (the “Board”) of Bone Biologics Corporation (the “Company”) determined to postpone the 2026 annual meeting of stockholders (the “Annual Meeting”), which was previously scheduled to be held on August 11, 2026. The Company intends to file a Definitive Proxy Statement on Schedule 14A with the Securities and Exchange Commission that includes an additional proposal to be voted on by stockholders and the Board determined additional time was necessary for stockholders to consider the proxy materials. The Annual Meeting will be held at the Company’s offices, 2 Burlington Woods Drive, Ste 100, Burlington, MA 01803, on September 28, 2026 at 11:30 a.m. Eastern Time and the new record date for the Annual Meeting will be August 6, 2026.
The company postponed its annual stockholder meeting by an undisclosed amount seven weeks, from August 11 to September 28, 2026. The delay is to accommodate an additional proposal that will be included in the proxy statement and to give stockholders adequate time to review the materials. The record date has been reset to August 6, 2026.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jul 28, 2026 · How we verify